Pharmafile Logo
Pharmafocus logo
Advanced Search
tamzin_redston

Tamzin Redston joines Wave

August 14, 2015
Medical Communications Tamzin Redston, Wave communications

Tamzin Redston has been appointed programme director at Wave, the specialist medical education company.Tamzin joins Wave with a background of …

Appointment
Keytruda image

Merck in immuno-oncology collaboration with major cancer research centre

August 14, 2015
Research and Development Cancer, Merck, keytruda, oncology

Merck is teaming up with the University of Texas to evaluate Merck’s anti-PD-1 therapy, Keytruda, in combination with other treatmentsA team …

News
GSK image

GSK closes Legionella-hit US site

August 14, 2015
Manufacturing and Production GSK, Legionnaire's disease, legionella, manufacturing, production

GSK has temporarily shut down its manufacturing site in North Carolina due to the discovery of the bacteria which causes …

News
Code of Practice

Bayer’s complaint over ‘misleading’ Novartis eye drug claims upheld

August 14, 2015
Medical Communications Bayer, Eylea, Lucentis, Novartis, PMCPA, code of conduct

The industry’s code of conduct regulator has ruled in favour of Bayer in a dispute claims made by Novartis when …

News
Pfizer image

Pfizer offers to pay for UK Lyrica switches

August 13, 2015
Lyrica, NHS England, Pfizer, generics, neuropathic pain, patents, pregabalin

Pfizer is to pay the administrative costs of GPs to switch patients to Lyrica from generic versions of pregabalin, as …

News

Abbvie and Roche report success in Phase II leukaemia trial

August 13, 2015
Research and Development AbbVie, Breakthrough Therapy Designation, CLL, EMA, FDA, Roche, chronic lymphocytic leukaemia, leukaemia, venetoclax

AbbVie plans to submit regulatory applications for its leukaemia drug venetoclax to the FDA and the EMA before the end …

News

Cost of diabetes treatment in England rises

August 12, 2015
Manufacturing and Production, Sales and Marketing HSCIC, NHS, diabetes, health and social care information centre, prescribing

As diabetes patients increase in numbers the cost of treating the disease in England has increased to more than £800 …

News
contrave

Orexigen and Takeda reboot Contrave collaboration

August 12, 2015
Research and Development Contrave, FDA, Takeda, orexigen, weight loss drugs

Orexigen has agreed to foot the $200 million bill for a new trial to prove its claims that Contrave, the …

News
Kim Kardashian West Diclegis post

FDA warns drugmaker over Kim Kardashian West promo

August 12, 2015
Sales and Marketing Diclegis, Duchesnay, FDA, kim kardashian

Model and media personality Kim Kardashian West’s social media promotion of the morning sickness drug Diclegis has landed its producer …

News
Novavax

Novavax rides high on crest of RSV vaccine wave

August 12, 2015
Research and Development AbbVie, MedImmune, Novavax, RSV, vaccines

The vaccine development company Novavax has announced positive top-line data from a mid-stage clinical trial of its candidate vaccine against …

News
gareth-thurston-web

Gareth Thurston joins Cello Health Consulting

August 12, 2015
Medical Communications Cello, Gareth Thurston, cello health

Cello Health has appointed Gareth Thurston as a consultant following his prior experience in pharmaceutical marketing. Gareth has over 20 …

Appointment
Opdivo

Bristol-Myers Squibb launches Opdivo in the UK for lung cancer

August 12, 2015
Sales and Marketing BMS, Bristol-Myers Squibb, NSCLC, immunotherapy, lung cancer, non small cell lung cancer, non-small cell lung cancer, opdivo

The immuno-oncology drug Opdivo is available in the UK for people with lung cancer, after Bristol-Myers Squibb launched the drug …

News
Daiichi Sankyo

Daiichi scores another NICE nod for Lixiana

August 12, 2015
Sales and Marketing Daichii Sankyo, Daiichi, Lixiana, atrial fibrillation, edoxaban

NICE has recommended in draft guidance the anti-blood clotting drug Daiichi Sankyo’s Lixiana for preventing stroke and blood clots in …

News
MedImmune building

MedImmune and Inovio collaborate on cancer vaccine

August 11, 2015
Manufacturing and Production, Research and Development AstraZeneca, HPV, Inovio, MedImmune, cancer vaccines, cervical cancer, oncology

MedImmune has entered into a license agreement and collaboration with Inovio, a biotechnology company developing DNA-based immunotherapies for cancer and …

News
aprecias_zipdose_technology_in_action

Aprecia boosts 3D printing facilities at new US site

August 11, 2015
Manufacturing and Production, Research and Development

Aprecia Pharmaceuticals, which scored a world-first by becoming the first manufacturer to gain FDA approval for a three-dimensional printed (3DP) …

News
world map

Cold chain management and transportation of medicines

August 11, 2015
Manufacturing and Production CEIV, IATA, Transport, cold chain, fly pharma, fly pharma conference, logistics, supply chain, transportation, vaccines

Riekert Bruinink, a member of the guideline drafting committee and the Dutch health inspectorate, has a very simple explanation of …

Feature
Pharma pill manufacturing

US to lead global contract manufacturing market by 2020

August 11, 2015
Manufacturing and Production APIs, United States, manufacturing, production

The global pharmaceutical contract manufacturing market was worth $58 billion in 2014 and is projected to reach $84 billion in 2020, according to a …

News
George Freeman

UK medical innovation backed with £18m Biomedical Catalyst fund

August 10, 2015
Research and Development, Sales and Marketing

Life Sciences Minister George Freeman has announced an £18 million fund for the next generation of UK medical advances. Twelve …

News
R&D

Sanofi, Evotec and Apeiron partner on immuno-oncology

August 10, 2015
Research and Development, Sales and Marketing Apeiron, Cancer, Evotec, Sanofi, immuno-oncology, immunotherapy, tumours

Sanofi is partnering with biotech companies Evotec and Apeiron to develop new cancer immuno-oncology therapies.The companies say the potential new …

News
Nucynta (tapentadol)

Takeover hostilities resume between Depomed and Horizon

August 10, 2015
Sales and Marketing Depomed, horizon, hostile bid, nucynta, takeover, tapentadol

The bitter takeover row between Horizon and Depomed has escalated after Depomed dismissed its suitor’s latest advances, and warned it …

News
The Gateway to Local Adoption Series

Latest content

Sandoz opens biosimilar development centre in Slovenia

June 19, 2026

Codis announces three senior business development appointments

June 18, 2026

US laboratory approval supports launch of lung cancer blood test

June 17, 2026

Study to examine ways of improving diabetes care for younger adults

June 16, 2026

Phase 2 endometriosis trial reaches recruitment milestone

June 15, 2026